Search for: "ALLERGAN, INC."
Results 1 - 20
of 381
Sorted by Relevance
|
Sort by Date
16 Jan 2014, 9:41 pm
Noonan -- If you have ever wondered how popular eyelash enhancers like RevitaLash and Latisse produce their effects, Allergan, Inc. v. [read post]
29 Jan 2013, 9:21 pm
Barr Laboratories, Inc., interesting. [read post]
2 Jun 2011, 5:00 am
Allergan, Inc. v. [read post]
1 Aug 2019, 4:31 am
Jane Lambert Patents Court (Mr Justice Atnold) Allergan, Inc and another v Aspire Pharma Ltd [2019] EWHC 1085 (Pat) (3 May 2019) Allergan Inc is the proprietor of European patent EP1753434 for an enhanced bimatoprost ophthalmic solution which its English subsidiary, Allergan Ltd. exploits by marketing a product containing 0.1 mg/ml (0.01%) bimatoprost for ophthalmic [read post]
2 Sep 2014, 9:41 pm
Allergan had asserted its 7,351,404 patent (the '404 patent) and Duke asserted its 7,388,029 patent (the '029 patent) after Apotex filed an ANDA for a generic version of Allergan's Latisse®, an ophthalmic solution comprising bimatoprost (a prostaglandin F-2-alpha ("PGF") analog) as the active ingredient. [read post]
13 Mar 2013, 8:34 am
IPNews® - Allergan, Inc. was granted partial summary judgment against Cosmetic Alchemy, LLC for inducing its customers to infringe Allergan’s patents that cover its popular eyelash growth drug Latisse. [read post]
30 Jan 2013, 8:22 am
Barr Laboratories, Inc. and Sandoz, Inc. were found by the lower court to not have sufficiently proven their claims that Allergan’s patent was invalid due to prior art and obviousness. [read post]
27 Oct 2009, 8:49 am
The United States District Court for the District of Delaware handed Allergan, Inc. [read post]
15 Apr 2019, 6:09 am
Here is the petition in Allergan Inc. v. [read post]
8 Sep 2019, 9:56 pm
Sandoz, Inc. [read post]
6 Apr 2016, 7:37 pm
Pfizer Inc. and Allergan PLC withdrew their planned $160 billion merger, ending what would have been the largest so-called inversion transaction. [read post]
26 Sep 2019, 11:53 am
Allergan USA, Inc. v. [read post]
4 May 2011, 2:00 am
Allergan Inc., 3:10-cv-00136, U.S. [read post]
15 Aug 2014, 12:37 pm
Rowe Price Group Inc., the Baltimore-based money manager, was among investors buying increased stakes in pharmaceutical company Allergan in the last quarter, according to Securities and Exchange Commission filings reported by Bloomberg News. [read post]
2 May 2013, 1:34 pm
By Jason Rantanen Allergan, Inc. v. [read post]
10 Nov 2014, 11:10 am
[This story previously appeared in Securities Regulation Daily.]By Anne Sherry, J.D.The Delaware Court of Chancery declined to issue declaratory relief blessing a hypothetical strategy by Allergan stockholders to replace the entire board at a special meeting, as the challenge to Allergan’s interpretation of the “similar item” provision in its governing documents was not ripe for review (In re Allergan, Inc. [read post]
6 May 2020, 1:51 pm
On May 5, 2020, the FTC approved AbbVie Inc. [read post]
9 Apr 2013, 7:23 am
., holding that a derivative suit against Botox-maker Allergan, Inc. should be dismissed because Allergan had already secured a judgment in its favor in a nearly identical suit in California. [read post]
12 Apr 2007, 9:48 pm
By Donald Zuhn -- On Thursday, Allergan, Inc. announced that the U.S. [read post]
12 Mar 2012, 9:20 am
In a resounding victory, Botox manufacturer Allergan, Inc. has secured a permanent injunction from a California federal court forbidding competitors Merz Pharmaceuticals and Merz Aesthetic from rolling out the sale of Xeomin for cosmetic purposes for the next ten months. [read post]
